Takehiro Ochi - Concepedia

Author

Takehiro Ochi

Mochida Pharmaceutical (Japan)

Also Known As

Takehiro OCHI, Takehiro Ochi

Publications

479

Citations

H-Index

Concepts

All Affiliations

Mochida Pharmaceutical (Japan)Takeda (Japan)Astellas Pharma (Japan)Fujisawa City Hospital

About

Takehiro Ochi is an author at Mochida Pharmaceutical (Japan) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	16	423
2	Health Sciences	5	5	148
3	Natural Sciences	2	2	95
4	Social Sciences	2	2	30
5	Public Health	1	1	18

Takehiro Ochi

Publications

423

Citations

H-Index

Page 1

	Year	Citations
The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models Takehiro Ochi, Yukio Motoyama, Toshio Goto European Journal of Pharmacology Pain TherapyHealth SciencesBiochemistrySelective Cyclooxygenase-1 InhibitorPain Medicine	2000	95
Anti-inflammatory and analgesic effects of a novel pyrazole derivative, FR140423 Takehiro Ochi, Katsue Jobo-Magari, Atsuo Yonezawa, European Journal of Pharmacology InflammationMedicinal ChemistryPharmaceutical ScienceNovel Pyrazole DerivativePharmacological Study	1999	49
Studies on Anti-inflammatory Agents. VI. Synthesis and Pharmacological Properties of 2,3-Diarylthiophenes. Kiyoshi Tsuji, Katsuya Nakamura, Takashi Ogino, Chemical and Pharmaceutical Bulletin Pharmaceutical ScienceOrganic ChemistryChemistryPharmaceutical ChemistryInflammation	1998	46
Differential effect of FR122047, a selective cyclo‐oxygenase‐1 inhibitor, in rat chronic models of arthritis Takehiro Ochi, Toshio Goto British Journal of Pharmacology Rat Chronic ModelsImmunologyType Ii CollagenPharmacotherapyInflammatory Arthritis	2002	41
Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice Takehiro Ochi, Y. Ohkubo, Seitaro Mutoh Biochemical Pharmacology InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune Disease	2003	34
The antinociceptive effect induced by FR140423 is mediated through spinal 5-HT2A and 5-HT3 receptors Takehiro Ochi, Toshio Goto European Journal of Pharmacology 5-Ht3 ReceptorsPain SyndromeSpinal Cord InjuryPain MedicineMedicine	2000	22
Effect of road transportation on the serum biochemical parameters of cynomolgus monkeys and beagle dogs Takehiro Ochi, Azusa Yamada, Yuki Naganuma, Journal of Veterinary Medical Science Working DogSerum Biochemical ParametersLaboratory Animal StudyAnimal StudyBody Composition	2016	19
Effects of Transport Stress on Serum Alkaline Phosphatase Activity in Beagle Dogs Takehiro Ochi, Ippei Nishiura, Yoshimi Hirano, EXPERIMENTAL ANIMALS Working DogAlkaline PhosphataseVeterinary ResearchHealthy Beagle DogsLaboratory Animal Study	2013	18
Anesthetic Effect of a Combination of Medetomidine-Midazolam-Butorphanol in Cynomolgus Monkeys (<i>Macaca fascicularis</i>) Takehiro Ochi, Ippei Nishiura, Yoshimi Hirano, Journal of Veterinary Medical Science Anesthetic EffectAnesthetic MechanismPharmacotherapyMe-mi-bu CombinationAnesthetic Administration	2014	17
Anti-inflammatory Effect of FR140423, a Novel Selective Cyclo-oxygenase-2 Inhibitor, in Rat Adjuvant Arthritis Without Gastrointestinal Side Effects Takehiro Ochi, Toshio Goto Journal of Pharmacy and Pharmacology InflammationRheumatologyMedicinal ChemistryPaw OedemaAnti-inflammatory	2000	15

Page 1